Given the prominent roles in CNS development, overall intolerance to variation of the GRID genes (Supplementary Table S1) and accumulating evidence of their role in neurological disorders, we sought to establish critical domains and residues in GluD1 and GluD2 in order to facilitate clinical variant classification in these genes. This evidence concerns the gene GLUD2 and nervous system disorder.